|
Company News, New Products, Meetings where Cypex is Exhibiting
Company
News
17th
June 2007
Cypex appoints Krishgen Biosystems as a distributor for the Indian market.
2nd
November 2006
Cypex appoints Precision Technologies as a distributor for Singapore, Malaysia, Indonesia and Thailand.
22nd
June 2006
Cypex maintains Investors
in People recognition.
17th
April 2006
Cypex starts operating from new premises in Dundee Medipark.
10th
October 2005
Building work starts on Cypex's new headquarters and laboratory in
Dundee Medipark.
10th
January 2005
Cypex announces plans to build new headquarters and laboratory in
prestigious Medipark in Dundee. Planning permission has been granted
for a building that is three times the size of Cypex's current premises.
10th
December 2004
Cypex appoints AiBST as a distributor for the African
market.
1st
July 2004
Cypex
appoints
Jingmei Biotech Co. Ltd. as a distributor for its products in China and MGP Co. Ltd as a
distributor in the Czech Republic.
6th
October 2003
Cypex
and BioDynamics Research Ltd, Rushden, UK sign joint manufacturing /
distribution agreement. Cypex will distribute fine chemicals and drug
metabolites manufactured by BioDynamics Research Ltd as Cypex branded
products for drug metabolism studies.
28th
August 2003
Cypex achieves Investors
in People recognition.
1st
June 2003
Cypex appoints M/S LabPro India as a distributor for the Indian market.
18th
October 2002
Cypex acquires a non-exclusive licence from Brookhaven Science
Associates LLC for commercial use of their T7 RNA polymerase technology.
23rd
September 2002
Cypex appoints Nosan Corporation as a distributor for the Japanese market.
21st
March 2002
PPD Discovery (Wilmington, N.C.) announces licence agreement with
Cypex, giving Cypex a worldwide, non-exclusive licence to use PPD
Discovery's proprietary Pharmazyme™ technology. PPD Discovery
press
release
22nd
January 2002
Cypex appoints XenoTech as a distributor for the North American market.
6th
December 2001
Cypex is upgraded to ISO9001:2000 Quality Standard.
1st
October 2001
Cypex is appointed European distributor for Nosan Corporation's range
of anti-human cytochrome P450 antibodies.
New
products
8th
May 2008
CYP2C9*2R EasyCYP Bactosomes (co-expressed recombinant human CYP2C9*2
and human NADPH-cytochrome P450 reductase) released for sale.
23rd
April 2008
CYP2C9*3R EasyCYP Bactosomes (co-expressed recombinant human CYP2C9*3
and human NADPH-cytochrome P450 reductase) released for sale.
16th
April 2008
Recombinant human aldehyde
oxidase
released for sale.
24th
March 2008
CYP2C9*3R
Bactosomes (co-expressed recombinant human CYP2C9*3
and human NADPH-cytochrome P450 reductase) released for sale.
16th
January 2008
CYP2E1BR
Bactosomes and CYP2E1BR EasyCYP Bactosomes
(co-expressed recombinant human CYP2E1
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
18th
December 2007
CYP2C9BHR
Bactosomes, CYP2C9BHR
EasyCYP Bactosomes, CYP2C9BR
Bactosomes and CYP2C9BR EasyCYP Bactosomes
(co-expressed recombinant human CYP2C9
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
5th December
2007
The CYP2C8 metabolite desethylamodiaquine
is
released
for sale.
12th
November 2007
The CYP2C8 substrate amodiaquine
is
released
for sale.
13th
September 2007
CYP3A4BLR
Bactosomes and CYP3A4BLR EasyCYP Bactosomes
(co-expressed recombinant human CYP3A4
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
7th
September 2007
CYP3A4BR
Bactosomes and CYP3A4BR EasyCYP Bactosomes
(co-expressed recombinant human CYP3A4
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
1st
August 2007
The CYP3A4 and CYP2J2 substrate terfenadine is
released
for sale.
18th
July 2007
The specific CYP2C19 inhibitor (-)-N-3-benzylphenobarbital is
released
for sale.
20th
February 2007
EasyCYP
range further extended with the release of CYP4A11LR EasyCYP Bactosomes for
sale.
4th
October 2006
EasyCYP
range further extended with the release of CYP1B1LR, CYP2C18LR,
CYP2D6*2R,
CYP2D6*10R
and CYP2J2LR
EasyCYP Bactosomes for sale.
18th
August 2006
CYP2J2LR Bactosomes (co-expressed recombinant human CYP2J2
and human NADPH-cytochrome P450 reductase) released for sale.
4th
August 2006
CYP2A13R Bactosomes (co-expressed recombinant human CYP2A13
and human NADPH-cytochrome P450 reductase) released for sale.
3rd
August 2006
EasyCYP
range further extended with the release of CYP1A1R, CYP3A5LR and CYP4A11R
EasyCYP Bactosomes for sale.
10th
July 2006
EasyCYP
range further extended with the release of CYP1A2LR, CYP2C9R, CYP2C19LR,
CYP2D6LR
and CYP3A4LR
EasyCYP Bactosomes for sale.
8th
June 2006
Larger pack size (5 mg) of 6alpha-hydroxypaclitaxel released
for sale.
2nd
June 2006
CYP2A13LR Bactosomes (co-expressed recombinant human CYP2A13
and human NADPH-cytochrome P450 reductase) released for sale.
30th
May 2006
Diclofenac
released for sale.
23rd
May 2006
EasyCYP
range extended with the release of CYP2A6R, CYP2B6R and CYP2E1R
EasyCYP Bactosomes for sale.
6th
April 2006
CYP2C9*2R Bactosomes (co-expressed recombinant human CYP2C9*2
and human NADPH-cytochrome P450 reductase) released for sale.
28th
March 2006
Ketoconazole
released for sale.
17th
March 2006
Paclitaxel
released for sale.
5th
December 2005
Tienilic acid
released for sale.
21st
October 2005
CYP2D6*39R Bactosomes (co-expressed recombinant human CYP2D6*39
and human NADPH-cytochrome P450 reductase) released for sale.
18th
October 2005
Human SULT1B1
released for sale.
3rd
October 2005
CYP2D6*10R Bactosomes (co-expressed recombinant human CYP2D6*10
and human NADPH-cytochrome P450 reductase) released for sale.
16th
August 2005
3-O-methylfluorescein
released for sale.
21st
June 2005
Omeprazole
released for sale.
19th
May 2005
EasyCYP
range extended with the release of CYP2C8R EasyCYP Bactosomes for sale.
15th
April 2005
First
five CYPs in the new convenient EasyCYP format released for sale.
9th
December 2004
MAMC/HAMC
(aminomethylcoumarin derivatives) released for sale.
7th
December 2004
MFC/BFC/HFC
(trifluoromethylcoumarin derivatives) released for sale.
3rd
December 2004
Larger pack size (5 mg) of 4'-hydroxydiclofenac released for
sale.
5th
November 2004
CYP2C19LR Bactosomes (co-expressed recombinant human CYP2C19
and human NADPH-cytochrome P450 reductase) released for sale.
15th
September 2004
Radiolabelled 7-ethoxycoumarin
released for sale.
10th
September 2004
Sheep anti-human
SULT1A3 antiserum released for sale.
24th
June 2004
7-hydroxyquinoline
released for sale.
17th
June 2004
CYP2D6*2R Bactosomes (co-expressed recombinant human CYP2D6*2
and human NADPH-cytochrome P450 reductase) released for sale.
Visit
our stand at the following meetings:
10th
European ISSX Meeting
Vienna, Austria
May 18 - 21 2008
17th
International Symposium on Microsomes & Drug Oxidations
Saratoga Springs, NY, USA
July 6 - 10 2008
15th
North American ISSX Meeting
San Diego, CA, USA
October 12 - 16 2008
Contact
Cypex for more information.
|
